| Identification | Back Directory | [Name]
Benzamide, N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-2-methoxy-4-(methylamino)- | [CAS]
2227154-23-4 | [Synonyms]
Benzamide, N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-2-methoxy-4-(methylamino)- | [Molecular Formula]
C18H29N3O4S | [MOL File]
2227154-23-4.mol | [Molecular Weight]
383.51 |
| Hazard Information | Back Directory | [Uses]
LB-102 is an orally active inhibitor of dopamine D2, D3, and 5-HT7 receptors, which can be used in research on schizophrenia and other psychiatric disorders[1]. | [References]
[1] Wong D F, et al. PET clinical study of novel antipsychotic LB-102 demonstrates unexpectedly prolonged dopamine receptor target engagement[J]. Neuropsychopharmacology, 2024: 1-6. DOI:10.1038/s41386-024-01951-x |
|
|